A phase II, open label study of AT-101 in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. Evaluation of two dose regimens

被引：28
|
作者：
Castro, Januario E. [1 ,2 ]
Loria, Olivier J. [1 ,2 ]
Aguillon, Robier A. [1 ,2 ]
James, Danelle [1 ,2 ]
Llanos, Cesar A. [1 ,2 ]
Rassenti, Laura [1 ,2 ]
Wood, Brian A. [3 ]
Homlund, Jon T. [3 ]
Kipps, Thomas J. [1 ,2 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Chronic Lymphocyt Leukemia Res Consortium, La Jolla, CA 92093 USA
[3] ASCENTA Therapeut Inc, San Diego, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3119.3119
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3119
引用
收藏
页码：917A / 918A
页数：2
相关论文
共 50 条
  • [1] A phase II, open label study of AT-101 in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.
    Castro, Januario E.
    Olivier, Loria J.
    Robier, Aguillon A.
    Danelle, James
    Carlos, Suarez J.
    Bi-Ying, Yeh
    Thomas, Kipps J.
    BLOOD, 2006, 108 (11) : 803A - 803A
  • [2] Rituximab® and high dose methylprednisolone (HDMP) for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia.
    Castro, JE
    Bole, J
    Prada, CE
    Kipps, TJ
    BLOOD, 2004, 104 (11) : 690A - 690A
  • [3] UPDATED RESULTS OF A PHASE II STUDY OF LENALIDOMIDE AND RITUXIMAB IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA.
    Piris-Villaespesa, M.
    Chavez, J.
    Dalia, S.
    Veliz, M.
    Lancet, Jeffrey
    Bello, C.
    Turba, E.
    Shah, B.
    Komrokji, R.
    Sokol, L.
    Locke, F.
    Kharfan-Dabaja, M.
    Sotomayor, E.
    Pinilla-Ibarz, J.
    HAEMATOLOGICA, 2013, 98 : 46 - 46
  • [4] Phase I study of combination rituximab with apolizumab in relapsed/refractory B-cell lymphoma and chronic lymphocytic leukemia.
    Dunleavy, K
    White, T
    Grant, N
    Shovlin, M
    Stetler-Stevenson, M
    Pittaluga, S
    Jaffe, ES
    Marti, G
    Janik, J
    Wilson, WH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 586S - 586S
  • [5] The Combination of Lenalidomide and Rituximab Induces Complete and Partial Responses In Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia.
    Ferrajoli, Alessandra
    Badoux, Xavier
    O'Brien, Susan
    Wierda, William G.
    Faderl, Stefan
    Estrov, Zeev
    Pasia, Manolo
    Lerner, Susan
    Kantarjian, Hagop
    Keating, Michael J.
    BLOOD, 2010, 116 (21) : 600 - 600
  • [6] Phase I study of rituximab and CAMPATH-1H in patients with relapsed or refractory chronic lymphocytic leukemia.
    Nabhan, C
    Tallman, MS
    Riley, MB
    Fitzpatrick, J
    Gordon, LI
    Gartenhaus, R
    Kuzel, T
    Siegel, R
    Rosen, ST
    BLOOD, 2001, 98 (11) : 365A - 365A
  • [7] Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
    Chavez, Julio C.
    Piris-Villaespesa, Miguel
    Dalia, Samir
    Powers, John
    Turba, Elyce
    Nodzon, Lisa
    Komrokji, Rami
    Sokol, Lubomir
    Locke, Frederick L.
    Lancet, Jeffrey
    Sotomayor, Eduardo M.
    Kharfan-Dabaja, Mohamed A.
    Pinilla-Ibarz, Javier
    LEUKEMIA RESEARCH, 2016, 47 : 78 - 83
  • [8] Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Badoux, Xavier C.
    Keating, Michael J.
    Wen, Sijin
    Wierda, William G.
    O'Brien, Susan M.
    Faderl, Stefan
    Sargent, Rachel
    Burger, Jan A.
    Ferrajoli, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) : 584 - 591
  • [9] EFFICACY OF THE COMBINATION OF BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Zagoskina, T.
    Zotina, E.
    Ovsepyan, V.
    Shardakov, V.
    HAEMATOLOGICA, 2014, 99 : 591 - 591
  • [10] Ofatumumab in combination with high-dose methylprednisolone for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia.
    Castro, Januario E.
    Choi, Michael Y.
    Carvajal, Tomas
    Li, Hongying
    James, Danelle Frances
    Messer, Karen
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345